Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.
Cohen
R A
RA
Robert Dawson Evans Department of Clinical Research, Boston University School of Medicine, Mass, USA.
Vanhoutte
P M
PM
D000818:Animals; D001685:Biological Factors / Q000302:isolation & purification / Q000502:physiology*; D006152:Cyclic GMP / Q000502:physiology*; D003920:Diabetes Mellitus / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000502:physiology*; D011464:Epoprostenol / Q000502:physiology; D006801:Humans; D006937:Hypercholesterolemia / Q000503:physiopathology; D006973:Hypertension / Q000503:physiopathology; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology*; D014664:Vasodilation / Q000502:physiology*
D001685:Biological Factors; C067410:endothelium-dependent hyperpolarization factor; D009569:Nitric Oxide; D011464:Epoprostenol; D006152:Cyclic GMP